Piscataway, NJ, October 5, 2022– Camber Pharmaceuticals is pleased to announce the addition of Acyclovir Oral Suspension to its current portfolio.
Acyclovir Oral Suspension is a synthetic nucleoside analogue active against herpes viruses.
Acyclovir Oral Suspension from Camber is available in 200 mg/5 mL strength in 473 mL bottles.
To find out more about Acyclovir Oral Suspension please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
